Cite
Amaddeo G, Brustia R, Allaire M, et al. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area. JHEP Rep. 2020;3(1):100199doi: 10.1016/j.jhepr.2020.100199.
Amaddeo, G., Brustia, R., Allaire, M., Lequoy, M., Hollande, C., Regnault, H., Blaise, L., Ganne-Carrié, N., Séror, O., Larrey, E., Lim, C., Scatton, O., El Mouhadi, S., Ozenne, V., Paye, F., Balladur, P., Dohan, A., Massault, P. P., Pol, S., Dioguardi Burgio, M., Vilgrain, V., Sepulveda, A., Cauchy, F., Luciani, A., Sommacale, D., Leroy, V., Roudot-Thoraval, F., Bouattour, M., Nault, J. C. (2021). Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area. JHEP reports : innovation in hepatology, 3(1), 100199. https://doi.org/10.1016/j.jhepr.2020.100199
Amaddeo, Giuliana, et al. "Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area." JHEP reports : innovation in hepatology vol. 3,1 (2021): 100199. doi: https://doi.org/10.1016/j.jhepr.2020.100199
Amaddeo G, Brustia R, Allaire M, Lequoy M, Hollande C, Regnault H, Blaise L, Ganne-Carrié N, Séror O, Larrey E, Lim C, Scatton O, El Mouhadi S, Ozenne V, Paye F, Balladur P, Dohan A, Massault PP, Pol S, Dioguardi Burgio M, Vilgrain V, Sepulveda A, Cauchy F, Luciani A, Sommacale D, Leroy V, Roudot-Thoraval F, Bouattour M, Nault JC. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area. JHEP Rep. 2021 Feb;3(1):100199. doi: 10.1016/j.jhepr.2020.100199. Epub 2020 Dec 22. PMID: 33163949; PMCID: PMC7604130.
Copy
Download .nbib